Stay up to date on our entrepreneurs, events, research and more. Check out our August newsletter here.
Sistema.bio, a social enterprise operating in the agritech space led by Endeavor Entrepreneurs Camilo Pages and Alexander Eaton, recently closed a Series A investment round of US$12 Million. Endeavor Catalyst participated in the investment round following the lead of investors including DILA CAPITAL, Engie RDE Fund, EcoEnterprise Fund and others.
Sistema.bio Co-founders Alexander Eaton and Camilo Pages
Sistema.bio was founded in 2010 and works with smallholder farmers to address the challenges of poverty, food security and climate change, providing access to innovative biodigester technology, training and financing to make farmers more productive, efficient and sustainable. Sistema Biobolsa helps farmers put waste to work: utilizing patented, high-quality, and affordable Biobolsa biodigesters, farmers convert animal manure into renewable energy and organic fertilizer to power their houses and fertilize their crops. With as few as two cows, a Biobolsa biodigester produces enough clean and renewable biogas (a type of biofuel) to meet all energy needs for cooking and heating in a rural household as well as organic fertilizer to improve crop yield for up to five hectares.
According to the World Bank, biodigester technology improves crop yields and reduces reliance on traditional fuels, thereby improving the overall economic performance of the farm. Along with the digester itself, the Mexico-based firm develops affordable and high-quality biogas equipment customized for small and remote farms, making them more environmentally-friendly and profitable, at the same time.
The company operates globally with the potential to bring clean-energy and sustainable agricultural practices to 100 million farmers. This new funding will help Sistema.bio move closer to fulfilling this goal; following the investment round, Sistema.bio announced plans to expand throughout Mexico, South America, Kenya, and India over the next three years, bringing their biodigester technology and their impact to over 200,000 smallholder farmers.
“This fundraise allows us to invest in manufacturing, operational reach and product development. Combined, we will have the economies of scale to reach deeper into our established regions and build partnerships with like-minded institutions already serving smallholder farmers. This is common sense technology for over 100 million livestock farmers worldwide, and we are well positioned to be a reference brand for this market,” said Graham Day, CFO of Sistema.bio.
Sistema.Bio’s deep commitment to the intersections of environmental sustainability, inclusive business, social empowerment and technological innovation as well as their immense potential to scale earned them their selection to the Endeavor network in 2017.
Alexander Eaton, CEO and Co-founder of Sistema.bio, shared his excitement about partnering with Endeavor and others who support their mission: “We are excited to partner with institutions that share our commitment to sustainable agriculture and that fight against climate change and poverty. The investment will enable Sistema.bio to accelerate our growth and impact in Latin America, East Africa, and India.”
Endeavor Catalyst is the innovative co-investment fund of Endeavor, set up to invest exclusively in Endeavor Entrepreneur-led companies and to sustain Endeavor’s long-term operations in a mission-aligned way. Since launching in January 2012, Endeavor Catalyst has raised over $110M in donated and invested capital, and invested in more than 100 Endeavor companies in over 20 markets. To date, Endeavor Catalyst has co-invested alongside a number of leading venture capital and growth equity funds, including Accel Partners, General Atlantic, NEA, Sequoia Capital and Tiger Global. Investments include Globant (NYSE: GLOB) in Argentina, Yemeksepeti.com (acquired by Delivery Hero) in Turkey, and dr. consulta in Brazil. Learn more here.
© 2019 Endeavor Global, Inc.
All Rights Reserved
Endeavor Global, Inc.
900 Broadway, Suite 301
New York, NY 10003
1 (212) 352-3200
Website by BRITEWEB